To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Disease mongering is a term used to describe a perceived attempt by pharmaceutical companies to promote public awareness of relatively minor conditions or diseases with the aim of increasing sales of medication. Examples include male-type baldness and certain social phobias. In discussions specifically about the validity of psychiatry, the term is frequently also used by proponents of the antipsychiatry movement and Scientology based critics to discredit psychiatry, neurobiological disorders, and the medications used for treatment. Examples include ADHD and bipolar disorder.
Additional recommended knowledge
Proponents of this practice argue that the pharmaceutical industry is only providing the public with information about its options and that actual prescription is a matter to be discussed between patient and doctor. Opponents, however, claim that this approach leads to the unnecessary prescription of drugs, that its motivation is only to profit the drug companies, and that it may actually harm instead of help patients.
A 2006 Newcastle, New South Wales conference, reported in PLoS Medicine, explored the phenomenon further Journalist Moynihan satirised it in a BMJ "news" item that appeared in its April Fool's Day edition 2006, titled "Scientists find new disease: motivational deficiency disorder".
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Disease_mongering". A list of authors is available in Wikipedia.|